THINKER
2017
Transplanting Hepatitis C Kidneys into Negative Kidney Recipients
In 20 HCV-negative recipients of hepatitis-C-viraemic donor kidneys, antiviral therapy achieved a sustained virologic response in every patient.
Result
Primary endpoint: Sustained virologic response at 12 weeks (SVR12)
SVR12 100% (20/20); median 6-month creatinine 1.1 mg/dL.
- Subtopic
- HCV-positive donors
- Design
- Open-label single-centre pilot
- Enrolled
- 10 patients
- Relevance
- Supporting: context rather than must-know.
- Source
- Goldberg DS, et al. N Engl J Med. 2017;376(24):2394-2395.doi 10.1056/NEJMc1705221
Discussion & critique
Unlocked a previously discarded donor pool; now standard practice in many US centres.